ニューヨークにおける慢性骨髄性白血病の臨床試験
ニューヨーク内の拠点で、慢性骨髄性白血病に関する15件の研究が参加者を募集しています。
ニューヨーク内の都市
公式研究テキスト（英語）
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Queens Hospital Center, Jamaica
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Stony Brook University Medical Center, Stony Brook
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069Study of Olverembatinib (HQP1351) in Patients With CML-CP
- Ascentage Investigative Site #1068, Rochester
- Ascentage Investigative Site #1053, Shirley
- Ascentage Investigative Site #1160, Stony Brook
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/15更新 · NCT06423911Cord Blood Transplant in Adults With Blood Cancers
- Memorial Sloan Kettering Cancer Center, New York
被験者募集中第2相
21歳〜65歳 · 全性別 · 2026/09/11更新 · NCT05884333Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
- Columbia University Medical Center New York Presbyterian, New York
被験者募集中第2相
1歳〜18歳 · 全性別 · 2026/09/02更新 · NCT07354074Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation
- Roswell Park Comprehensive Cancer Center, Buffalo
- Memorial Sloan Kettering Cancer Center, New York
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/25更新 · NCT04838041A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Roswell Park Cancer Institute, Buffalo
- North Shore University Hospital, Lake Sucess
- Cohen Children's Medical Center of New York, New Hyde
- 他9件
被験者募集中観察研究
全年齢 · 全性別 · 2026/07/06更新 · NCT01351545Asciminib Roll-over Study
- Memorial Sloan Kettering, New York
被験者募集中第4相
7歳〜100歳 · 全性別 · 2026/07/06更新 · NCT04877522Impact of Targeted Therapy on Cancer-Related Cognitive Impairment
- University of Rochester NCORP Research Base, Rochester
被験者募集中観察研究健康なボランティア歓迎
18歳以上 · 全性別 · 2026/06/10更新 · NCT07638007Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant
- Wilmot Cancer Institute, University of Rochester, Rochester
被験者募集中早期第1相
18歳〜75歳 · 全性別 · 2026/06/03更新 · NCT03964506A Study to Learn About the Study Medicine Bosulif in Adult Patients With Chronic Myeloid Leukemia(CML).
- Pfizer New York, New York
被験者募集中観察研究
20歳以上 · 全性別 · 2026/04/14更新 · NCT06297161A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
- Memorial Sloan Kettering Cancer Center, New York
- Montefiore Medical Center, The Bronx
被験者募集中第1相
18歳以上 · 全性別 · 2026/04/01更新 · NCT05304377A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
- Memorial Sloan Kettering, New York
被験者募集中第2相
18歳〜66歳 · 全性別 · 2026/03/17更新 · NCT06859424A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
- Memorial Sloan Kettering Cancer Center, New York
被験者募集中第1相
12歳以上 · 全性別 · 2026/03/16更新 · NCT06994676A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
- Memorial Sloan Kettering Cancer Center - Main Campus, New York
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/01/12更新 · NCT06163430ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML
- Roswell Park Comprehensive Cancer Center, Buffalo
被験者募集中第1相
18歳以上 · 全性別 · 2025/11/04更新 · NCT03595917ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。